查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1874013

肌酸酐測量市場

Creatinine Measurement Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

預計肌酸酐測量市場將從 2024 年的 5.577 億美元成長到 2031 年的 9.8251 億美元，2031 年至 2031 年的年複合成長率(CAGR) 為 8.4%。該市場的一個重要趨勢預計將是腎功能即時檢測的興起。

肌酸酐測量市場分析

老年人群尤其容易患上慢性腎臟疾病。美國糖尿病協會2021年的一項研究表明，約有3,840萬美國人（佔總人口的11.6%）患有糖尿病，其中約30%的患者年齡在65歲及以上。糖尿病會顯著增加腎衰竭的風險；美國國家腎臟基金會的一項研究估計，全球每年約有30%的糖尿病患者會發展為腎臟疾病。因此，老年人口的成長可能會在未來幾年推動肌酸酐檢測市場的發展。

肌酸酐測量市場概覽

肌酸酐檢測是一種用於評估腎功能和識別腎臟疾病的診斷方法。尿液中肌酸酐水平升高可能提示腎臟損傷或慢性腎臟病、急性腎損傷等疾病。市場擴張的主要驅動力是慢性腎臟病發病率的上升和老年人口的成長。然而，向新型生物標記的過渡可能會在預測期內阻礙市場成長。

肌酸酐測量市場的促進因素和機遇

慢性腎病發生率上升將有利於市場

根據美國國家腎臟基金會統計，慢性腎臟病（CKD）的全球盛行率正在上升，影響全球約10%的人口，每年有數百萬人因缺乏足夠的治療而死亡。超過200萬人接受透析或腎臟移植治療，主要集中在五個已開發國家：美國、日本、德國、巴西和義大利，而這五個國家的人口總和僅佔全球人口的12%。 2024年全球疾病負擔研究報告指出，慢性腎臟病導致了全球15%的死亡。

鑑於慢性腎臟病盛行率不斷上升，它已被公認為一項重大的全球健康挑戰。美國腎臟病學會 (ASN) 指出，分子診斷技術的進步正在改善腎臟疾病患者的治療管理。因此，慢性腎臟病發病率的上升，以及肌酸酐檢測在評估腎臟健康方面的優勢，預計將在預測期內提升對肌酸酐檢測設備的需求。

發展中國家的新興市場

發展中地區，特別是亞太地區，醫療保健產業的蓬勃發展為市場參與者帶來了巨大的機會。這些地區龐大的患者群體推動了對先進診斷技術的需求。例如，印度人口占全球總人口的18%，卻佔全球腎臟疾病負擔的約17%。此外，透析治療數量的不斷增加也顯示腎臟疾病盛行率顯著上升。全球疾病負擔研究估計，光是中國就有1.195億腎臟疾病患者。因此，腎臟疾病病例的快速成長，加上診斷檢測能力的不足，預計將在2031年之前為市場創造豐厚的成長機會。

肌酸酐測量市場細分分析

對肌酸酐測量市場進行分析的關鍵細分市場包括污染物、技術和食品類型。

  • 市場分為試劑盒和試劑，其中試劑盒在 2023 年將佔據更大的市場佔有率。
  • 按類型分類，市場分為酶法和 Jaffe 動力學法，其中酶法在 2023 年的市場佔有率領先。
  • 從樣本類型來看，市場分為血液或血清和尿液，其中血液或血清產品在 2023 年佔據主導地位。
  • 對於最終用戶而言，市場分為醫院、診斷實驗室和其他實體，其中醫院在 2023 年將引領市場。

肌酸酐測量市場的地理分析

肌酸酐測量市場報告的地理範圍分為五個區域：北美、亞太、歐洲、中東和非洲以及南美和中美洲。

在北美，肌酸酐檢測市場目前正經歷顯著成長。推動這一成長的因素包括：患有各種腎臟疾病的老年人口不斷增加、透析治療的有利報銷政策、醫療保健支出不斷成長、提供肌酸酐檢測服務的醫院和診所數量不斷增加，以及技術進步和主要市場參與者的存在。

此外，美國有利的報銷政策進一步推動了市場成長，促進了手術過程中導尿管的使用。許多保險公司承保實驗室服務，其中聯邦醫療保險（Medicare）根據服務項目，透過醫師收費標準（PFS）或臨床實驗室收費標準（CLFS）進行報銷。此外，實驗室也為其他政府計畫（如醫療補助計畫（Medicaid）、三軍醫療保險（TRICARE）和聯邦員工健康福利計畫（FEHBP））以及商業保險計畫的受益人提供服務。

肌酸酐測量市場報告範圍

肌酸酐測量市場的最新發展

肌酸酐檢測市場評估是基於從一手和二手研究中收集的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。以下是該市場近期在創新、業務拓展和策略方面的一些發展動態：

  • 2022年11月1日，創新酶業宣布推出用於生產診斷試劑盒的原料，包括用於膽固醇、肌酸激酶、肌酸酐、遊離脂肪酸、同型半胱氨酸、唾液酸和甘油三酯等多種檢測試劑盒的酶，確保為可靠的實驗提供高品質的產品。 （資料來源：創新酶業，新聞稿）
  • 2022年3月，Nova Biomedical在所有中歐國家推出了Nova Max Pro肌酸酐/eGFR檢測系統，旨在透過在醫院外的即時檢測環境中改善腎臟疾病的篩檢和早期發現，從而提升腎臟護理水平。 （來源：Nova Biomedical，新聞稿）

肌酸酐測量市場報告的覆蓋範圍和交付成果

這份題為《肌酸酐檢測市場規模及預測（2021-2031）》的報告對市場進行了全面分析，涵蓋以下領域：

  • 全球、區域和國家層面所有關鍵細分市場的市場規模和預測。
  • 市場動態，包括促進因素、限制因素和主要機會。
  • 肌酸酐檢測市場趨勢。
  • 詳細的PEST和SWOT分析。
  • 分析關鍵市場趨勢、全球和區域框架、主要參與者、法規和最新發展。
  • 產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展。
  • 深入的公司概況。

目錄

第1章：引言

第2章：肌酸酐檢測市場及主要結論

第3章：研究方法

  • 覆蓋範圍
  • 二手研究
  • 初步研究

第4章：肌酸酐測定及市場概況

  • 概述
  • PEST分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲和中美洲
  • 專家意見

第5章：肌酸酐測定及主要市場動態

  • 市場促進因素
    • 慢性腎臟疾病盛行率不斷上升
    • 老年人口不斷增加
  • 市場限制
    • 轉向新型生物標記
  • 市場機遇
    • 發展中國家的新興市場
  • 未來趨勢
    • 床邊腎功能檢測
  • 影響分析

第6章：肌酸酐檢測市場及全球分析

  • 全球肌酸酐檢測市場收入預測與分析
  • 全球肌酸酐檢測市場（依地域分類）－預測與分析
  • 關鍵參與者的市場定位

第7章：肌酸酐檢測市場分析及產品分類

  • 概述
  • 肌酸酐檢測市場收入佔有率（按產品分類）（2024 年和 2031 年）
  • 套件
  • 試劑

第8章：肌酸酐檢測市場及類型

  • 概述
  • 肌酸酐檢測市場（按類型分類），2024 年和 2031 年（%）
  • 酵素法
  • 賈菲動力學方法

第9章：肌酸酐檢測市場及依樣本類型分類

  • 概述
  • 肌酸酐檢測市場（按樣本類型分類），2024 年和 2031 年（%）
  • 血液或血清
  • 尿

第10章：肌酸酐檢測市場分析及最終用戶分類

  • 概述
  • 肌酸酐檢測市場（按最終用戶分類）（2024 年和 2031 年）
  • 醫院
  • 診斷實驗室
  • 其他

第11章：肌酸酐檢測市場及地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
      • 英國
    • 法國
    • 西班牙
    • 義大利
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第12章：肌酸酐檢測市場及產業概況

  • 概述
    • 肌酸酐測量市場參與者的最新動態

第13章：肌酸酐檢測市場及主要公司概況

  • Siemens Healthineers AG
  • Abbott
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Danaher
  • Cayman Chemical
  • Randox Laboratories Ltd
  • Fujifilm Wako Pure Chemical Corporation
  • Beijing Leadman Biochemical Co., Ltd.
  • Shanghai Fosun Pharmaceutical Group Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Beijing Jiuqiang Biotechnology Co., Ltd.
  • Diazyme Laboratories, Inc.
  • Dialab GmbH
  • Maccura Biotechnology Co.

第14章：附錄

簡介目錄
Product Code: TIPBT00002180

The Creatinine Measurement Market is anticipated to grow from US$ 557.70 million in 2024 to US$ 982.51 million by 2031, reflecting a compound annual growth rate (CAGR) of 8.4% during the period from 2031 to 2031. A significant trend in this market is expected to be the rise of point-of-care testing for renal function.

Analysis of the Creatinine Measurement Market

The elderly population is particularly susceptible to chronic kidney diseases. Research by the American Diabetes Association in 2021 indicated that around 38.4 million Americans, or 11.6% of the population, are affected by diabetes, with approximately 30% of these individuals being 65 years or older. Diabetes significantly increases the risk of kidney failure; a study from the National Kidney Foundation estimates that about 30% of diabetic patients globally develop kidney disease each year. Therefore, the growing elderly demographic is likely to drive the growth of the creatinine measurement market in the coming years.

Overview of the Creatinine Measurement Market

Creatinine measurement is a diagnostic method used to evaluate kidney function and identify kidney diseases. High levels of creatinine in urine can indicate kidney damage or conditions such as chronic kidney disease or acute kidney injury. The market's expansion is primarily driven by the rising incidence of chronic kidney diseases and the increasing elderly population. However, the transition towards new biomarkers may hinder market growth during the forecast period.

Drivers and Opportunities in the Creatinine Measurement Market

Rising Incidence of Chronic Kidney Diseases to Benefit the Market

According to the National Kidney Foundation, the global prevalence of chronic kidney disease (CKD) is on the rise, affecting about 10% of the world's population, with millions dying annually due to lack of access to adequate treatment. Over 2 million individuals receive treatment through dialysis or kidney transplants, primarily in five developed nations: the US, Japan, Germany, Brazil, and Italy, which together account for only 12% of the global population. The 2024 Global Burden of Disease study reported that chronic kidney diseases contribute to 15% of global mortality.

Given the increasing prevalence of chronic kidney diseases, it is recognized as a significant global health challenge. The American Society of Nephrology (ASN) notes that advancements in molecular diagnostics are improving management for patients with kidney disorders. Consequently, the rising incidence of chronic kidney diseases, along with the advantages of creatinine measurement in assessing kidney health, is expected to enhance the demand for creatinine measurement devices throughout the forecast period.

Emerging Markets in Developing Nations

The expanding healthcare sector in developing regions, particularly in Asia Pacific, presents substantial opportunities for market participants. The large patient population in these areas is driving the demand for advanced diagnostic technologies. For example, India, which comprises 18% of the global population, accounts for about 17% of the global burden of kidney diseases. Additionally, the increasing number of dialysis procedures indicates a significant rise in renal disease prevalence. Estimates from the Global Burden of Disease suggest that China alone has 119.5 million patients with renal diseases. Thus, the rapid increase in kidney disease cases, combined with the gap in diagnostic test availability, is expected to create lucrative growth opportunities for the market by 2031.

Segmentation Analysis of the Creatinine Measurement Market

Key segments contributing to the analysis of the creatinine measurement market include contaminants, technology, and food type.

  • The market is categorized into Kits and Reagents, with the Kits segment holding a larger share in 2023.
  • By type, the market is divided into the Enzymatic Method and Jaffe's Kinetic Method, with the enzymatic method segment leading in market share in 2023.
  • In terms of sample type, the market is segmented into Blood or Serum and Urine, with blood or serum products dominating in 2023.
  • For end users, the market is classified into hospitals, diagnostic laboratories, and other entities, with hospitals leading the market in 2023.

Geographical Analysis of the Creatinine Measurement Market

The geographical scope of the creatinine measurement market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

In North America, the creatinine measurement market is currently experiencing significant growth. Factors contributing to this growth include an increasing elderly population with various kidney diseases, favorable reimbursement policies for dialysis, rising healthcare expenditures, and a growing number of hospitals and clinics offering creatinine measurement services, along with technological advancements and the presence of key market players.

Moreover, the favorable reimbursement landscape in the US is further propelling market growth by enhancing the adoption of urinary catheters during surgical procedures. Many insurance providers cover laboratory services, with Medicare offering reimbursements through either the Physician Fee Schedule (PFS) or the Clinical Laboratory Fee Schedule (CLFS), depending on the service. Additionally, laboratories provide services to beneficiaries of other government programs such as Medicaid, TRICARE, and the Federal Employee Health Benefit Plan (FEHBP), as well as commercial plans.

Scope of the Creatinine Measurement Market Report

Recent Developments in the Creatinine Measurement Market

The creatinine measurement market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Below are some recent developments in the market regarding innovations, business expansions, and strategies:

  • On November 1, 2022, Creative Enzymes announced the launch of raw materials for manufacturing diagnostic kits, including enzymes for various assay kits such as cholesterol, creatine kinase, creatinine, free fatty acid, homocysteine, sialic acid, and triglyceride kits, ensuring high-quality products for reliable experiments. (Source: Creative Enzymes, Press Release)
  • In March 2022, Nova Biomedical introduced the Nova Max Pro Creatinine/eGFR Meter System across all CE countries, aimed at enhancing kidney care through improved screening and early detection of kidney disease in point-of-care settings outside hospitals. (Source: Nova Biomedical, Press Release)

Coverage and Deliverables of the Creatinine Measurement Market Report

The report titled "Creatinine Measurement Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key segments.
  • Market dynamics including drivers, restraints, and key opportunities.
  • Trends in the creatinine measurement market.
  • Detailed PEST and SWOT analysis.
  • Analysis of key market trends, global and regional frameworks, major players, regulations, and recent developments.
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
  • In-depth company profiles.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Creatinine Measurement Market and By Product
    • 1.3.2 Global Creatinine Measurement Market and By Type
    • 1.3.3 Global Creatinine Measurement Market and By Sample Type
    • 1.3.4 Global Creatinine Measurement Market and By End User
    • 1.3.5 Global Creatinine Measurement Market and By Geography

2. Creatinine Measurement Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Creatinine Measurement and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America
    • 4.2.2 Europe
    • 4.2.3 Asia Pacific
    • 4.2.4 Middle East and Africa
    • 4.2.5 South and Central America
  • 4.3 Expert Opinion

5. Creatinine Measurement and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Kidney Disorders
    • 5.1.2 Growing Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Shift Toward Novel Biomarkers
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Markets in Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Point-of-Care Renal Functioning Testing
  • 5.5 Impact Analysis

6. Creatinine Measurement Market and Global Analysis

  • 6.1 Global Creatinine Measurement Market Revenue Forecast And Analysis
  • 6.2 Global Creatinine Measurement Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Creatinine Measurement Market Analysis and By Product

  • 7.1 Overview
  • 7.2 Creatinine Measurement Market Revenue Share, by Product (2024 and 2031)
  • 7.3 Kits
    • 7.3.1 Overview
    • 7.3.2 Kits: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Reagents
    • 7.4.1 Overview
    • 7.4.2 Reagents: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)

8. Creatinine Measurement Market and By Type

  • 8.1 Overview
  • 8.2 Creatinine Measurement Market, by Type, 2024 and 2031 (%)
  • 8.3 Enzymatic Method
    • 8.3.1 Overview
    • 8.3.2 Enzymatic Method: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Jaffe’s Kinetic Method
    • 8.4.1 Overview
    • 8.4.2 Jaffe’s Kinetic Method: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)

9. Creatinine Measurement Market and By Sample Type

  • 9.1 Overview
  • 9.2 Creatinine Measurement Market, by Sample Type, 2024 and 2031 (%)
  • 9.3 Blood or Serum
    • 9.3.1 Overview
    • 9.3.2 Blood or Serum: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Urine
    • 9.4.1 Overview
    • 9.4.2 Urine: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)

10. Creatinine Measurement Market Analysis and By End User

  • 10.1 Overview
  • 10.2 Creatinine Measurement Market, by End User (2024 and 2031)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: Creatinine Measurement Market, Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Diagnostic Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostic Laboratories: Creatinine Measurement Market, Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Creatinine Measurement Market, Revenue and Forecast to 2031 (US$ Million)

11. Creatinine Measurement Market and Geographic Analysis

  • 11.1 North America: Creatinine Measurement Market
    • 11.1.1 Overview
    • 11.1.2 North America: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
    • 11.1.3 North America: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
    • 11.1.4 North America: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
    • 11.1.5 North America: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
    • 11.1.6 North America: Creatinine Measurement Market, by End User , 2024 and 2031 (USD Million)
    • 11.1.7 North America: Creatinine Measurement Market, by Country, 2024 and 2031 (%)
    • 11.1.8 US: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.1 US: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.2 US: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.1.8.3 US: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.1.8.4 US: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.1.8.5 US: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.1.9 Canada: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.1 Canada: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.2 Canada: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.1.9.3 Canada: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.1.9.4 Canada: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.1.9.5 Canada: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.1.10 Mexico: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.1 Mexico: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.2 Mexico: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.1.10.3 Mexico: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.1.10.4 Mexico: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.1.10.5 Mexico: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
  • 11.2 Europe: Creatinine Measurement Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Creatinine Measurement Market - Revenue and Forecast to 2031 (USD Million)
    • 11.2.3 Europe: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
    • 11.2.4 Europe: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
    • 11.2.5 Europe: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
    • 11.2.6 Europe: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.7 Europe: Creatinine Measurement Market, by Country, 2018 and 2031 (%)
    • 11.2.8 Germany: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.1 Germany: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.2 Germany: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.2.8.3 Germany: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.8.4 Germany: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.2.8.5 Germany: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.9 UK: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.1 UK: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.2 United Kingdom: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.2.9.3 United Kingdom: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.9.4 United Kingdom: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.2.9.5 United Kingdom: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.10 France: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.1 France: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.2 France: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.2.10.3 France: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.10.4 France: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.2.10.5 France: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.11 Spain: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.1 Spain: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.2 Spain: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.2.11.3 Spain: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.11.4 Spain: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.2.11.5 Spain: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.2.12 Italy: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.1 Italy: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.2 Italy: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.2.12.3 Italy: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.2.12.4 Italy: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.2.12.5 Italy: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
  • 11.3 Asia Pacific: Creatinine Measurement Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Creatinine Measurement Market - Revenue and Forecast to 2031 (USD Million)
    • 11.3.3 Asia Pacific: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
    • 11.3.4 Asia Pacific: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
    • 11.3.5 Asia Pacific: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
    • 11.3.6 Asia Pacific: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.7 Asia Pacific: Creatinine Measurement Market, by Country, 2018 and 2031 (%)
    • 11.3.8 China: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.1 China: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.2 China: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.3.8.3 China: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.8.4 China: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.3.8.5 China: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.9 Japan: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.1 Japan: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.2 Japan: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.3.9.3 Japan: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.9.4 Japan: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.3.9.5 Japan: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.10 India: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.1 India: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.2 India: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.3.10.3 India: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.10.4 India: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.3.10.5 India: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.11 South Korea: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.1 South Korea: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.2 South Korea: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.3.11.3 South Korea: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.11.4 South Korea: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.3.11.5 South Korea: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.3.12 Australia: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.1 Australia: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.2 Australia: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.3.12.3 Australia: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.3.12.4 Australia: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.3.12.5 Australia: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
  • 11.4 Middle East and Africa: Creatinine Measurement Market
    • 11.4.1 Overview
    • 11.4.2 Middle East and Africa: Creatinine Measurement Market - Revenue and Forecast to 2031 (USD Million)
    • 11.4.3 Middle East and Africa: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
    • 11.4.4 Middle East and Africa: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
    • 11.4.5 Middle East and Africa: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
    • 11.4.6 Middle East and Africa: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.7 Middle East and Africa: Creatinine Measurement Market Share by Country and 2024 and 2031, (%)
    • 11.4.8 Saudi Arabia: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.1 Saudi Arabia: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.2 Saudi Arabia: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.4.8.3 Saudi Arabia: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.8.4 Saudi Arabia: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.4.8.5 Saudi Arabia: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.9 UAE: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.1 UAE: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.2 UAE: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.4.9.3 UAE: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.9.4 UAE: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.4.9.5 UAE: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.4.10 South Africa: Creatinine Measurement Market and Revenue and Forecast to 2031 (US$ Million)
      • 11.4.10.1 South Africa: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.2 South Africa: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.4.10.3 South Africa: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.4.10.4 South Africa: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.4.10.5 South Africa: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
  • 11.5 South and Central America: Creatinine Measurement Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Creatinine Measurement Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.5.3 South and Central America: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
    • 11.5.4 South and Central America: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
    • 11.5.5 South and Central America: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
    • 11.5.6 South and Central America: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.5.7 South and Central America: Creatinine Measurement Market, by Country, 2018 and 2031 (%)
    • 11.5.8 Brazil: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.1 Brazil: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.2 Brazil: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.5.8.3 Brazil: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.5.8.4 Brazil: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.5.8.5 Brazil: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)
    • 11.5.9 Argentina: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.1 Argentina: Creatinine Measurement Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.2 Argentina: Creatinine Measurement Market, by Product, 2024 and 2031 (USD Million)
      • 11.5.9.3 Argentina: Creatinine Measurement Market, by Type, 2024 and 2031 (USD Million)
      • 11.5.9.4 Argentina: Creatinine Measurement Market, by Sample Type, 2024 and 2031 (USD Million)
      • 11.5.9.5 Argentina: Creatinine Measurement Market, by End User, 2024 and 2031 (USD Million)

12. Creatinine Measurement Market and Industry Landscape

  • 12.1 Overview
    • 12.1.1 Recent Developments by Players in the Creatinine Measurement Market

13. Creatinine Measurement Market and Key Company Profiles

  • 13.1 Siemens Healthineers AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Abbott
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Thermo Fisher Scientific Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 F. Hoffmann-La Roche Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Danaher
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Cayman Chemical
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Randox Laboratories Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Fujifilm Wako Pure Chemical Corporation
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Beijing Leadman Biochemical Co., Ltd.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Shanghai Fosun Pharmaceutical Group Co., Ltd.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Beijing Jiuqiang Biotechnology Co., Ltd.
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Diazyme Laboratories, Inc.
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Dialab GmbH
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Maccura Biotechnology Co.
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms